OOIR: Observatory of International Research

Papers

(The median citation count of Current Rheumatology Reports is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Decoding the Intricacies of Statin-Associated Muscle Symptoms	110
The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature	109
Future of Low-Dose Computed Tomography and Dual-Energy Computed Tomography in Axial Spondyloarthritis	47
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response	46
Current Epidemiology and Risk Factors for the Development of Hand Osteoarthritis	41
AA Amyloidosis: A Contemporary View	40
Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know	38
Deep Insight into the Role of MIF in Spondyloarthritis	37
Ultrasound Beyond Joints: A Review of Extra-Articular Applications in Rheumatology	36
Current perspective on infections and mitigation strategies in primary systemic vasculitis	35
The Role of Antiphospholipid Antibodies in COVID-19	31
MicroRNAs in Axial Spondylarthritis: an Overview of the Recent Progresses in the Field with a Focus on Ankylosing Spondylitis and Psoriatic Arthritis	28
How to Monitor Disease Activity of Axial Spondyloarthritis in Clinical Practice	28
Identification of Common Pathogenic Pathways Involved in Hemochromatosis Arthritis and Calcium Pyrophosphate Deposition Disease: a Review	28
Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review	28
Broadening the Scope of Resilience in Chronic Pain: Methods, Social Context, and Development	27
Unveiling the Potential of Probiotics in Osteoarthritis Management	27
Synovial Tissue Insights into Heterogeneity of Rheumatoid Arthritis	26
Exploring the Complex Relationship Between Microbiota and Systemic Lupus Erythematosus	26
MRI in the Diagnosis and Treatment Response Assessment of Chronic Nonbacterial Osteomyelitis in Children and Adolescents	25
Classification Criteria for ANCA Associated Vasculitis – Ready for Prime Time?	22
Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases	22
Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention	22
Updates on Clinical Trials in Systemic Lupus Erythematosus	21
Narrative Review: Peripheral Arterial Disease in Patients with Hyperuricemia and Gout	21

An Update on the Diagnosis and Management of Calcium Crystal Disease	21
Immune Checkpoint Inhibitor Associated Rheumatoid Arthritis	21
Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?	20
Epidemiology of Antiphospholipid Syndrome in the General Population	20
Calcium Pyrophosphate Crystal Deposition: Insights to Risks Factors and Associated Conditions	18
Modification of Gut Microbiota in Inflammatory Arthritis: Highlights and Future Challenges	18
Air Pollution and Rheumatoid Arthritis Risk and Progression: Implications for the Mucosal Origins Hypothesis and Climate Change for RA Pathogenesis	17
Newer Autoantibodies and Laboratory Assessments in Myositis	17
Digital Health and Self-Management in Idiopathic Inflammatory Myopathies: A Missed Opportunity?	17
Advances in Juvenile Spondyloarthritis	16
Keratinocytes – Amplifiers of Immune Responses in Systemic Lupus Erythematosus	16
Calcium Pyrophosphate Crystal Formation and Deposition: Where Do we Stand and What Does the Future hold?	16
Digital Approaches for Myositis	16
IgA Vasculitis in Adults: a Rare yet Challenging Disease	15
Intravenous Immunoglobulin in Idiopathic Inflammatory Myopathies: a Practical Guide for Clinical Use	15
How Has Molecular Biology Enhanced Our Undertaking of axSpA and Its Management	15
Assessment of Physical Activity and Muscle Function in Adult Inflammatory Myopathies	14
What to Know About Biopsy Sampling and Pathology in Vasculitis?	14
Enthesitis in Psoriatic Arthritis, the Sonographic Perspective	13
Spectrum of Spondyloarthritis Among Chinese Populations	13
An Update on Kawasaki Disease	13
Correction to: Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update	13
Expanding Roles of Noncoding RNAs in the Pathogenesis of Systemic Lupus Erythematosus	12
From Psoriasis to Psoriatic Arthritis: Ultrasound Insights Connecting Psoriasis with Subclinical Musculoskeletal Inflammation and the Path to Psoriatic Arthritis	12
Syndesmophyte Growth in Ankylosing Spondylitis: from Laboratory to Bedside	12
Neuroimmune Mechanisms Underlying Post-acute Sequelae of SARS-CoV-2 (PASC) Pain, Predictions from a Ligand-Receptor Interactome	12
A Review of Difficult-to-Treat Rheumatoid Arthritis: Definition, Clinical Presentation, and Management	11
Advances in the Treatment of Behcet’s Disease	11
Gaining Insight into Updated MR Imaging for Quantitative Assessment of Cartilage Injury in Knee Osteoarthritis	11
Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature	10
Mesangial Cells in Lupus Nephritis	10
Role of IFN-α in Rheumatoid Arthritis	10
Machine Learning Approaches to the Prediction of Osteoarthritis Phenotypes and Outcomes	10
Effect of Osteoporosis Treatments on Osteoarthritis Progression in Postmenopausal Women: A Review of the Literature	10
Year in Review in Axial Spondyloarthritis Clinical Research and Guidelines: SPARTAN 2023 Annual Meeting Proceedings	10
Cannabis for Rheumatic Disease Pain: a Review of Current Literature	10
Updating the 2019 ACR/SAA/SPARTAN Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis (SPARTAN 2024 Annual Meeting Proceedings)	10
What Has Dual Energy CT Taught Us About Gout?	9
Use of Imaging in Axial Spondyloarthritis for Diagnosis and Assessment of Disease Remission in the Year 2022	9
Do Disease-Modifying Anti-rheumatic Drugs and Exercise Therapy Have a Combined Effect on Disease Activity in Patients with RA? A Scoping Review	9
Paediatric Rheumatology Fails to Meet Current Benchmarks, a Call for Health Equity for Children Living with Juvenile Idiopathic Arthritis, Using Digital Health Technologies	8
The Interplay of Biomechanical and Biological Changes Following Meniscus Injury	8
Gout, Hyperuricemia and Psoriatic Arthritis: An Evolving Conundrum	8
Axial Spondyloarthritis in Japan	8
TLR7 Signaling in Lupus B Cells: New Insights into Synergizing Factors and Downstream Signals	8
Axial Spondyloarthritis and Diagnostic Challenges: Over-diagnosis, Misdiagnosis, and Under-diagnosis	8
Localized Forms of Vasculitis	8
Hyperuricemia, Gout, and the Brain—an Update	7
Systemic Lupus Erythematosus and COVID-19	7
Update on Cutaneous Signs to Assist in the Diagnosis of Dermatomyositis	7

Undifferentiated Connective Tissue Disease: Comprehensive Review	7
Year in Review: Novel Insights in the Pathogenesis of Spondyloarthritis – SPARTAN 2024 Annual Meeting Proceedings	7
Screening for Spondyloarthritis in Patients with Inflammatory Bowel Disease - SPARTAN 2024 Annual Meeting Proceedings	7
Spectrum of Large and Medium Vessel Vasculitis in Adults: Primary Vasculitides, Arthritides, Connective Tissue, and Fibroinflammatory Diseases	7
Advancements in Imaging Techniques for Early Diagnosis and Management of Axial Spondyloarthritis	6
The Elusive Truth of Cannabinoids for Rheumatic Pain	6
Neuromodulation as a Potential Disease-Modifying Therapy for Osteoarthritis	6
Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens	6
The Role of Environmental Factors in the Development of Idiopathic Inflammatory Myopathies: a Narrative Review	6
Correction to: Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis	6
Microbial Mechanisms of Rheumatoid Arthritis Pathogenesis	6
An Update on Antiphospholipid Syndrome	6
Bone Health in Idiopathic Inflammatory Myopathies: Diagnosis and Management	6
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits	6
Trabecular Bone Score in Rheumatic Disease	6